Science The Precision Revolution: Oncolytic Viruses in Biotech Capital Steven HaynesApril 13, 2026April 20, 20260 Learn why oncolytic viruses are replacing the ‘carpet bombing’ approach of traditional oncology, creating new opportunities for biotech capital.
